India, New Zealand eye to increase collaboration in pharma sector
New Delhi: India and New Zealand are aiming to enhance cooperation in various sectors such as pharmaceuticals, digital trade, and cross-border payment systems to promote bilateral trade relations.
Issues to promote trade through these collaborations were discussed during the recent visit of Commerce Secretary Sunil Barthwal to New Zealand from April 26-27.
As per PTI report, the commerce ministry said that huge potential is there in both economies to further promote bilateral trade.
"The meetings reviewed progress on market access issues, economic cooperation projects and explored opportunities for new initiatives," it said.
Both sides discussed the establishment of robust bilateral economic dialogue architecture and the creation of working groups in sectors like Agriculture, Food Processing, Storage and Transportation, Forestry and Pharmaceuticals to facilitate ongoing collaboration on key trade and economic issues.
Deliberations also included increasing cooperation in kiwi fruit as well as the dairy sector.
The meetings addressed bilateral trade matters of mutual interest, including issues related to market access, non-tariff barriers, and sanitary (human and animal health) and phytosanitary (plant health) measures on products like grapes, okra and mangoes.
Mutual Recognition Arrangement (MRA) in organic products, and simplified homologation, including through mutual recognition of comparable domestic standards for vehicles, also figured in the discussions.
"Both parties reaffirmed their commitment to resolve these issues through constructive dialogue and cooperation," the ministry said.
Further, it said that collaboration in the areas of pharmaceuticals and medical devices was discussed at length, including the adoption of fast-tracking of regulatory processes and quality assessment of manufacturing facilities.
"Greater sourcing of medicines from India and cooperation in the medical device sector was also discussed," it said, adding that "both parties briefly explored opportunities for collaboration in digital trade, meeting nationally determined contributions, cross-border payment systems, among others".
Read also: Ajanta Pharma net profit increases 66 percent to Rs 203 crore in Q4
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd